share_log

Ashim Gupta Sells 10,000 Shares of UiPath Inc. (NYSE:PATH) Stock

Ashim Gupta Sells 10,000 Shares of UiPath Inc. (NYSE:PATH) Stock

Ashim Gupta 出售了 UiPath Inc.(纽约证券交易所代码:PATH)的 10,000 股股票
Defense World ·  2022/12/09 18:42

UiPath Inc. (NYSE:PATH – Get Rating) CFO Ashim Gupta sold 10,000 shares of the business's stock in a transaction that occurred on Monday, December 5th. The stock was sold at an average price of $13.50, for a total transaction of $135,000.00. Following the completion of the transaction, the chief financial officer now owns 1,515,341 shares of the company's stock, valued at $20,457,103.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

UiPath Inc.(纽约证券交易所股票代码:Path-Get Rating)首席财务官阿什姆·古普塔在12月5日星期一的一笔交易中出售了10,000股该公司的股票。该股以13.50美元的平均价格出售,总成交金额为135,000.00美元。交易完成后,首席财务官现在拥有1,515,341股公司股票,价值20,457,103.50美元。这笔交易是在提交给美国证券交易委员会的一份法律文件中披露的,该文件可以通过此超链接.

Ashim Gupta also recently made the following trade(s):

阿什姆·古普塔最近还进行了以下交易:

Get
到达
UiPath
UiPath
alerts:
警报:
  • On Tuesday, November 1st, Ashim Gupta sold 10,000 shares of UiPath stock. The stock was sold at an average price of $12.48, for a total transaction of $124,800.00.
  • On Monday, October 3rd, Ashim Gupta sold 10,000 shares of UiPath stock. The stock was sold at an average price of $12.69, for a total transaction of $126,900.00.
  • On Monday, September 12th, Ashim Gupta sold 30,000 shares of UiPath stock. The shares were sold at an average price of $15.02, for a total transaction of $450,600.00.
  • On Thursday, September 8th, Ashim Gupta sold 10,000 shares of UiPath stock. The shares were sold at an average price of $13.74, for a total transaction of $137,400.00.
  • 11月1日,星期二,阿什姆·古普塔出售了10,000股UiPath股票。该股以12.48美元的平均价格出售,总成交金额为124,800.00美元。
  • 10月3日,星期一,阿什姆·古普塔出售了10,000股UiPath股票。该股以12.69美元的平均价格出售,总成交金额为126,900.00美元。
  • 9月12日,星期一,阿什姆·古普塔出售了30,000股UiPath股票。这些股票以15.02美元的平均价格出售,总成交金额为450,600.00美元。
  • 9月8日,星期四,阿什姆·古普塔出售了10,000股UiPath股票。这些股票以13.74美元的平均价格出售,总成交额为137,400.00美元。

UiPath Stock Up 4.3 %

UiPath股价上涨4.3%

Shares of UiPath stock opened at $13.10 on Friday. The company has a fifty day moving average of $12.28 and a 200 day moving average of $16.01. UiPath Inc. has a fifty-two week low of $10.40 and a fifty-two week high of $48.68.

UiPath股票上周五开盘报13.10美元。该公司的50日移动均线切入位在12.28美元,200日移动均线切入位在16.01美元。UiPath Inc.的股价为52周低点10.40美元,52周高点为48.68美元。

UiPath (NYSE:PATH – Get Rating) last released its quarterly earnings data on Thursday, December 1st. The healthcare company reported ($0.09) EPS for the quarter, beating the consensus estimate of ($0.18) by $0.09. UiPath had a negative net margin of 34.99% and a negative return on equity of 17.19%. The business had revenue of $262.74 million during the quarter, compared to the consensus estimate of $248.07 million. On average, analysts anticipate that UiPath Inc. will post -0.55 earnings per share for the current year.
UiPath(NYSE:PATH-GET Rating)最近一次发布季度收益数据是在12月1日星期四。这家医疗保健公司公布了本季度每股收益(0.09美元),比普遍预期的(0.18美元)高出0.09美元。UiPath的净利润率为负34.99%,净资产回报率为负17.19%。该业务本季度的收入为2.6274亿美元,而普遍预期为2.4807亿美元。分析师平均预计,UiPath Inc.本年度每股收益将为0.55美元。

Analyst Ratings Changes

分析师评级发生变化

A number of equities research analysts have weighed in on the stock. Credit Suisse Group decreased their target price on shares of UiPath from $30.00 to $27.50 and set an "outperform" rating for the company in a research note on Wednesday, November 16th. BMO Capital Markets decreased their target price on shares of UiPath from $21.00 to $15.00 in a research note on Wednesday, September 7th. Mizuho boosted their target price on shares of UiPath from $14.00 to $15.00 in a research note on Friday, December 2nd. Evercore ISI reduced their price objective on UiPath to $17.00 in a research note on Friday, December 2nd. Finally, Cowen reduced their price objective on UiPath from $27.00 to $20.00 in a research note on Wednesday, September 7th. Nine analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat, UiPath presently has a consensus rating of "Hold" and a consensus price target of $22.23.

一些股票研究分析师对该股进行了加码。瑞士信贷集团在11月16日星期三的一份研究报告中将UiPath的股票目标价从30.00美元下调至27.50美元,并为该公司设定了“跑赢大盘”的评级。BMO Capital Markets在9月7日星期三的一份研究报告中将UiPath的目标价从21.00美元下调至15.00美元。瑞穗在12月2日星期五的一份研究报告中将UiPath的目标价从14.00美元上调至15.00美元。Evercore ISI在12月2日星期五的一份研究报告中将UiPath的目标价下调至17.00美元。最后,考恩在9月7日星期三的一份研究报告中将UiPath的目标价从27.00美元下调至20.00美元。9名分析师对该股的评级为持有,8名分析师对该股的评级为买入。根据MarketBeat的数据,UiPath目前的共识评级为持有,共识目标价为22.23美元。

Institutional Inflows and Outflows

机构资金流入和流出

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Prospera Financial Services Inc bought a new position in shares of UiPath during the 1st quarter valued at about $27,000. SeaCrest Wealth Management LLC bought a new position in shares of UiPath during the 2nd quarter valued at about $25,000. Banque Cantonale Vaudoise raised its position in shares of UiPath by 20,080.0% during the 2nd quarter. Banque Cantonale Vaudoise now owns 2,018 shares of the healthcare company's stock valued at $37,000 after buying an additional 2,008 shares in the last quarter. Householder Group Estate & Retirement Specialist LLC purchased a new stake in shares of UiPath during the 3rd quarter valued at about $25,000. Finally, CWM LLC purchased a new stake in shares of UiPath during the 2nd quarter valued at about $40,000. Institutional investors own 51.35% of the company's stock.

对冲基金和其他机构投资者最近改变了他们在该股的头寸。普罗斯佩拉金融服务公司在第一季度购买了UiPath的新头寸,价值约2.7万美元。Seacrest Wealth Management LLC在第二季度购买了UiPath的新头寸,价值约2.5万美元。第二季度,Canonale Vaudoise银行将其在UiPath股票的持仓增加了20080.0%。Canonale Vaudoise银行目前持有这家医疗保健公司2018股股票,价值3.7万美元,此前该行在上个季度又购买了2008股。持有者集团房地产和退休专业公司LLC在第三季度购买了UiPath的新股,价值约25,000美元。最后,CWM LLC在第二季度购买了UiPath的新股份,价值约40,000美元。机构投资者持有该公司51.35%的股票。

UiPath Company Profile

UiPath公司简介

(Get Rating)

(获取评级)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

UiPath Inc.提供端到端自动化平台,主要在美国、罗马尼亚和日本提供一系列机器人过程自动化(RPA)解决方案。该公司提供一套相互关联的软件来构建、管理、运行、参与、测量和治理组织内的自动化。

Recommended Stories

推荐故事

  • Get a free copy of the StockNews.com research report on UiPath (PATH)
  • Can Pfizer, Johnson & Johnson Continue Outperforming the Index?
  • This Is Why Daktronics Fell 40% In One Day
  • Is It Time To Throw In The Towel On Gamestop?
  • Why You Should Avoid Carvana Even if it Avoids Bankruptcy
  • Are Investors Hearing The End Of Spotify's Downtrend?
  • 在UiPath上免费获取StockNews.com研究报告的副本(路径)
  • 辉瑞、强生能否继续跑赢该指数?
  • 这就是为什么达科电子在一天内下跌了40%
  • 是时候在Gamestop上认输了吗?
  • 为什么你应该避免Carvana,即使它可以避免破产
  • 投资者是否听到了Spotify下跌趋势的终结?

Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.

接收UiPath Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对UiPath和相关公司的最新新闻和分析师评级的每日简明摘要。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发